OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome
Christina‐Nefeli Kontandreopoulou, Panagiotis Diamantopoulos, Despina Tiblalexi, et al.
Blood Advances (2021) Vol. 5, Iss. 22, pp. 4794-4805
Open Access | Times Cited: 23
Christina‐Nefeli Kontandreopoulou, Panagiotis Diamantopoulos, Despina Tiblalexi, et al.
Blood Advances (2021) Vol. 5, Iss. 22, pp. 4794-4805
Open Access | Times Cited: 23
Showing 23 citing articles:
Epidemiology and Pathogenesis of Myelodysplastic Syndrome
Lara K. Rotter, Shai Shimony, Kelly Ling, et al.
The Cancer Journal (2023) Vol. 29, Iss. 3, pp. 111-121
Open Access | Times Cited: 13
Lara K. Rotter, Shai Shimony, Kelly Ling, et al.
The Cancer Journal (2023) Vol. 29, Iss. 3, pp. 111-121
Open Access | Times Cited: 13
Relapsed acute myeloid leukemia in children and adolescents: current treatment options and future strategies
Sara Zarnegar‐Lumley, Kenneth J. Caldwell, Jeffrey E. Rubnitz
Leukemia (2022) Vol. 36, Iss. 8, pp. 1951-1960
Closed Access | Times Cited: 19
Sara Zarnegar‐Lumley, Kenneth J. Caldwell, Jeffrey E. Rubnitz
Leukemia (2022) Vol. 36, Iss. 8, pp. 1951-1960
Closed Access | Times Cited: 19
Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development
Priya Bisht, Vikash Kumar, Ruchi Pandey, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Priya Bisht, Vikash Kumar, Ruchi Pandey, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 19
Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions
Mireia Medrano, María Elena Muñoz Contreras, Teresa Caballero‐Velázquez, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 9, pp. 1529-1541
Open Access | Times Cited: 4
Mireia Medrano, María Elena Muñoz Contreras, Teresa Caballero‐Velázquez, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 9, pp. 1529-1541
Open Access | Times Cited: 4
WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment
Seiichi Okabe, Yuko Tanaka, Mitsuru Moriyama, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Seiichi Okabe, Yuko Tanaka, Mitsuru Moriyama, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
DNA Methylation Malleability and Dysregulation in Cancer Progression: Understanding the Role of PARP1
Rakesh Srivastava, Niraj Lodhi
Biomolecules (2022) Vol. 12, Iss. 3, pp. 417-417
Open Access | Times Cited: 12
Rakesh Srivastava, Niraj Lodhi
Biomolecules (2022) Vol. 12, Iss. 3, pp. 417-417
Open Access | Times Cited: 12
Integrative investigation of hematotoxic effects induced by low doses of lead, cadmium, mercury and arsenic mixture: In vivo and in silico approach
Katarina Živančević, Jovana Živanović, Katarina Baralić, et al.
The Science of The Total Environment (2024) Vol. 930, pp. 172608-172608
Closed Access | Times Cited: 2
Katarina Živančević, Jovana Živanović, Katarina Baralić, et al.
The Science of The Total Environment (2024) Vol. 930, pp. 172608-172608
Closed Access | Times Cited: 2
A novel α,β-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitor
Weijia Zhao, Min Mo, Jia Yu, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Open Access | Times Cited: 1
Weijia Zhao, Min Mo, Jia Yu, et al.
Medical Oncology (2024) Vol. 41, Iss. 5
Open Access | Times Cited: 1
PARP inhibition leads to synthetic lethality with key splicing-factor mutations in myelodysplastic syndromes
Fangliang Zhang, Jianai Sun, Lei Zhang, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 231-242
Closed Access | Times Cited: 1
Fangliang Zhang, Jianai Sun, Lei Zhang, et al.
British Journal of Cancer (2024) Vol. 131, Iss. 2, pp. 231-242
Closed Access | Times Cited: 1
Genetic and Epigenetic Biomarkers Associated with Early Relapse in Pediatric Acute Lymphoblastic Leukemia: A Focused Bioinformatics Study on DNA-Repair Genes
Walaa F. Albaqami, Ali A. Alshamrani, Ali A. Al‐Mubarak, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1766-1766
Open Access | Times Cited: 1
Walaa F. Albaqami, Ali A. Alshamrani, Ali A. Al‐Mubarak, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1766-1766
Open Access | Times Cited: 1
Combination strategies to promote sensitivity to cytarabine-induced replication stress in acute myeloid leukemia with and without DNMT3A mutations
Daniil E. Shabashvili, Yang Feng, Prabhjot Kaur, et al.
Experimental Hematology (2022) Vol. 110, pp. 20-27
Open Access | Times Cited: 6
Daniil E. Shabashvili, Yang Feng, Prabhjot Kaur, et al.
Experimental Hematology (2022) Vol. 110, pp. 20-27
Open Access | Times Cited: 6
The role of E3 ubiquitin ligase WWP2 and the regulation of PARP1 by ubiquitinated degradation in acute lymphoblastic leukemia
Xinxin Lu, Xinyue Huang, Haiqi Xu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Xinxin Lu, Xinyue Huang, Haiqi Xu, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapy
Daria Frank, Pradeep Kumar Patnana, Jan Vorwerk, et al.
Blood (2023) Vol. 142, Iss. 25, pp. 2175-2191
Open Access | Times Cited: 3
Daria Frank, Pradeep Kumar Patnana, Jan Vorwerk, et al.
Blood (2023) Vol. 142, Iss. 25, pp. 2175-2191
Open Access | Times Cited: 3
Analysis of core mutation and TET2/ASXL1 mutations DNA methylation profile in myelodysplastic syndrome
Yue Feng, Haiping Liang, Xingchun Luo, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 2
Yue Feng, Haiping Liang, Xingchun Luo, et al.
Hematology (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 2
Upregulation of interferon signaling predicts sustained complete remission in pediatric AML patients
Chiara Cugno, Shimaa Sherif, Aesha I. Ali, et al.
Research Square (Research Square) (2024)
Open Access
Chiara Cugno, Shimaa Sherif, Aesha I. Ali, et al.
Research Square (Research Square) (2024)
Open Access
Roles of DNMT3B and PARP1 Genes Expression in Cytogenetically Normal Acute Myeloid Leukemia
Hazem H. Mahmoud, Shahira KA Botros, Abdelhamid Fouad, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access
Hazem H. Mahmoud, Shahira KA Botros, Abdelhamid Fouad, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access
Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactions
Andrea Ghelli Luserna di Rorà, Mouna Jandoubi, Antonella Padella, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Andrea Ghelli Luserna di Rorà, Mouna Jandoubi, Antonella Padella, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Incidence, characteristics and outcome of therapy‐related myeloid neoplasms in women with epithelial ovarian cancer after exposure to poly‐ADPribose polymerase inhibitors: A cancer center experience
Evgenia Verrou, Prodromos Koutoukoglou, Evangelia Kontana, et al.
International Journal of Cancer (2024)
Open Access
Evgenia Verrou, Prodromos Koutoukoglou, Evangelia Kontana, et al.
International Journal of Cancer (2024)
Open Access
Role of the STING pathway in myeloid neoplasms: a prospero-registered systematic review of principal hurdles of STING on the road to the clinical practice
Letícia Rodrigues Sampaio, Ricardo Dyllan Barbosa Dias, João Vitor Caetano Goes, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access
Letícia Rodrigues Sampaio, Ricardo Dyllan Barbosa Dias, João Vitor Caetano Goes, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access
Metabolic and Regulatory Pathways Involved in the Anticancer Activity of Perillyl Alcohol: A Scoping Review of In Vitro Studies
Ana Carolina Batista Brochado, Josué de Moraes, Bruna Stéfanny Mota de Oliveira, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4003-4003
Open Access
Ana Carolina Batista Brochado, Josué de Moraes, Bruna Stéfanny Mota de Oliveira, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4003-4003
Open Access
A novel α,β-unsaturated ketone inhibits leukemia cell growth as PARP1 inhibitor
Weijia Zhao, Min Mo, Jia Yu, et al.
Research Square (Research Square) (2023)
Open Access
Weijia Zhao, Min Mo, Jia Yu, et al.
Research Square (Research Square) (2023)
Open Access
Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies
Tariq I. Mughal, Naveen Pemmaraju, Rafael Bejar, et al.
Hematological Oncology (2022) Vol. 40, Iss. 4, pp. 491-504
Open Access
Tariq I. Mughal, Naveen Pemmaraju, Rafael Bejar, et al.
Hematological Oncology (2022) Vol. 40, Iss. 4, pp. 491-504
Open Access
The Role of E3 ubiquitin Ligase WWP2 and the Regulation of PARP1 by Ubiquitinated Degradation in Apoptosis of Acute Lymphoblastic Leukemia
Lijun Zhang, Xinxin Lu, Xinyue Huang, et al.
Research Square (Research Square) (2022)
Open Access
Lijun Zhang, Xinxin Lu, Xinyue Huang, et al.
Research Square (Research Square) (2022)
Open Access
